Nursing Homes ResidentsTMG91NCT02164747
Assessment of Teleconsulting in Nursing Homes to Avoid Transportations to the Emergency Units
An observational study of Nursing Homes Residents, run by Assistance Publique - Hôpitaux de Paris at 5 sites in France.
Trial summary
The purpose of this study is to determine whether teleconsulting would be effective and cost-effective by reducing the patients transportations and the use of emergency units for nursing home residents. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Nursing Homes Residents
- What is being tested?
- Residents of nursing homes with telemedicine after implementation of telemedicine
- Type of treatment
- Medical device
- How many people
- 341 participants
- Where
- 5 sitesFrance
- Study dates
- Jan 2012to Dec 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Nursing home residents
Who may be able to join
- All residents of selected nursing homes
Who cannot join
- None
Trial locations and contacts
5 sites in 1 country.
5 sites in 1 country
France5 sites
Résidence La Gentilhommière
Boussy-Saint-Antoine, 91800
Résidence Les Tisserins
Évry, 91000
Résidence Notre Dame d'Espérance
Milly-la-Forêt, 91490
Le Centenaire
Pussay, 91740
Résidence de l'Orge
Saint-Germain-lès-Arpajon, 91180
About this study
The purpose of this study is to determine whether teleconsulting would be effective and cost-effective by reducing the patients transportations and the use of emergency units for nursing home residents.
- Conditions
- Nursing Homes Residents
- Being tested
- Residents of nursing homes with telemedicine after implementation of telemedicine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Residents of nursing homes with telemedicine after implementation of telemedicineDevice
| Study group | Role | What they receive |
|---|---|---|
| Control group before telemedicine | Residents of nursing homes without telemedicine before implementation of telemedicine in nursing homes with telemedicine | |
| Control group after telemedicine | Residents of nursing homes without telemedicine after implementation of telemedicine in nursing homes with telemedicine | |
| Exposed group, before telemedicine | Residents of nursing homes with telemedicine prior implementation of telemedicine | |
| Exposed group, after telemedicine | Residents of nursing homes with telemedicine after implementation of telemedicine Receives: Device: Residents of nursing homes with telemedicine after implementation of telemedicine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Length of hospital stay
Measured: Within 1 year after start of the study
Secondary outcomes (3)
Patient transportation to a emergency unit
Measured: Within 1 year after start of the study
Number of hospitalizations
Measured: Within 1 year after start of the study
Global costs
Measured: Within 1 year after start of the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2014 (estimated)
- Study startJan 2012
- Primary completionSep 2016
- Study completionDec 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Nursing Homes ResidentsStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 341 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- Agence Regionale de Sante d'Ile de France
- Responsible party
- Sponsor
- Investigators
- Isabelle Durand-Zaleski, MD, PhD, Principal investigator, DRCD URC Eco. Assistance Publique, Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02164747
- Sponsor's protocol ID
- TLM-TMG91
- Acronym
- TMG91
- Status last verified
- Jan 2017
- First submitted
- 13 Jun 2014
- Last updated
- 11 Jan 2017
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.
PubMed 22617736Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1.
PubMed 26857558
Study at a glance
From the registry record, last updated by the sponsor on 11 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Teleconsulting in Nursing Homes to Avoid Transportations to the Emergency Units
- ClinicalTrials.gov ID
- NCT02164747
- Acronym / sponsor ID
- TMG91 / TLM-TMG91
- Conditions
- Nursing Homes Residents
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 341 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- Agence Regionale de Sante d'Ile de France
- Study start
- Jan 2012
- Primary completion
- Sep 2016 (actual)
- Study completion
- Dec 2016 (actual)
- First posted
- 17 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether teleconsulting would be effective and cost-effective by reducing the patients transportations and the use of emergency units for nursing home residents.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Control group before telemedicine | – | –Residents of nursing homes without telemedicine before implementation of telemedicine in nursing homes with telemedicine |
| Control group after telemedicine | – | –Residents of nursing homes without telemedicine after implementation of telemedicine in nursing homes with telemedicine |
| Exposed group, before telemedicine | – | –Residents of nursing homes with telemedicine prior implementation of telemedicine |
| Exposed group, after telemedicine | – | Device: Residents of nursing homes with telemedicine after implementation of telemedicineResidents of nursing homes with telemedicine after implementation of telemedicine |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Nursing home residents
Key inclusion criteria (1 listed)
- All residents of selected nursing homes
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Residents of nursing homes with telemedicine after implementation of telemedicine | Device | Exposed group, after telemedicine |
Primary outcome
Length of hospital stay
Time frame: Within 1 year after start of the study
3 secondary outcomes
Patient transportation to a emergency unit
Time frame: Within 1 year after start of the study
Number of hospitalizations
Time frame: Within 1 year after start of the study
Global costs
Time frame: Within 1 year after start of the study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Jan 2017.
- Background: PubMed 22617736Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.
- Derived from this study: PubMed 26857558Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1.
- Individual participant dataSharing planned: No
Related trials for Nursing Homes Residents
Recruiting
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
Ageism, Loneliness
Not yet recruiting
A Virtual Reality Program for Nursing Home Residents With Physical Disabilities
Older Adults Institutionalized in Residential Homes
Not yet recruiting
SmartEnLite for Nursing Home Residents With Dementia
Alzheimer's Disease and Related Dementias, Alzheimer Disease and Related Dementias
Recruiting
Abbott ID NOW Point-of-Care Testing
Influenza, Influenza-like Illness
Not yet recruiting
Study on the Prevention of Weight Loss Through Physical Activity Among Nursing Home Residents
Appetite Loss in Aging, Anorexia of Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Isabelle Durand-Zaleski, MD, PhD principal investigator
DRCD URC Eco. Assistance Publique, Hôpitaux de Paris
5 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Nursing Homes Residents, run by Assistance Publique - Hôpitaux de Paris at 5 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Length of hospital stay (time frame: Within 1 year after start of the study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02164747, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2017.